The store will not work correctly when cookies are disabled.
4-(4-phenoxybenzoyl)phenylacetic acid
ID: ALA370016
Chembl Id: CHEMBL370016
PubChem CID: 11695657
Max Phase: Preclinical
Molecular Formula: C21H16O4
Molecular Weight: 332.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: 4-(4-Phenoxybenzoyl)Phenylacetic Acid | 4-(4-phenoxybenzoyl)phenylacetic acid|CHEMBL370016|BDBM50180895|PD181796
Canonical SMILES: O=C(O)Cc1ccc(C(=O)c2ccc(Oc3ccccc3)cc2)cc1
Standard InChI: InChI=1S/C21H16O4/c22-20(23)14-15-6-8-16(9-7-15)21(24)17-10-12-19(13-11-17)25-18-4-2-1-3-5-18/h1-13H,14H2,(H,22,23)
Standard InChI Key: VRBHQDUOTOPSLA-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.36 | Molecular Weight (Monoisotopic): 332.1049 | AlogP: 4.34 | #Rotatable Bonds: 6 |
Polar Surface Area: 63.60 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.59 | CX Basic pKa: ┄ | CX LogP: 4.57 | CX LogD: 1.23 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.68 | Np Likeness Score: -0.32 |
References
1. Salem OI, Frotscher M, Scherer C, Neugebauer A, Biemel K, Streiber M, Maas R, Hartmann RW.. (2006) Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids., 49 (2): [PMID:16420060] [10.1021/jm050728w] |